4
Changes in Ownership
Aligos Therapeutics, Inc. Filed Acc 0001209191-20-055562
10% owner acquired 1,906,191 shares (conversion)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Wellington Biomedical Innovation Master Investors (Cayman) I L.P. 10% owner | 2020-10-20 | Conversion | +1,335,048 | 1,335,048 | D | ||
| Wellington Biomedical Innovation Master Investors (Cayman) I L.P. 10% owner | 2020-10-20 | Conversion | +571,143 | 1,906,191 | D | ||
| Derivatives | |||||||
| Wellington Biomedical Innovation Master Investors (Cayman) I L.P. 10% owner | 2020-10-20 | Conversion · Series B-1 convertible Preferred Stock | −1,335,048 | 0 | D | ||
| Wellington Biomedical Innovation Master Investors (Cayman) I L.P. 10% owner | 2020-10-20 | Conversion · Series B-2 convertible Preferred Stock | −571,143 | 0 | D | ||
Loading xslF345X03/doc4.xml…